论文部分内容阅读
Randomized phase Ⅲ study on the effect of early intensification of rituximab in combination with 2-w
【作 者】
：
【机 构】
：
Department of Hematology,Erasmus MC Cancer Insitute,Rotterdam,Netherlands
【出 处】
：
2016年临床肿瘤学新进展学术研讨会
【发表日期】
：
2016年5期
其他文献
Atezolizumab(atezo)as first-line(1L)therapy in cisplatin-ineligible locally advanced/metastatic urot
会议
Limited versus extended pelvic lymphadenectomy in patients with bladder cancer undergoing radical cy
会议
OV21/PETROC:A randomized Gynecologic Cancer Intergroup(GCIG)phase Ⅱ study of intraperitoneal(IP)vers
会议
Baseline quality of life(QOL)as a predictor of stopping chemotherapy early,and of overall survival,i
会议
Crenolanib besylate,a type Ⅰ pan-FLT3 inhibitor,to demonstrate clinical activity in multiply relapse
会议
Final results of a phase Ⅲ randomized trial of CPX-351 versus 7+3 in older patients with newly diagn
会议
Phase Ⅲ non-inferiority study of cabazitaxel(C)20 mg/m2(C20)versus 25 mg/m2(C25)in patients(pts)with
会议
会议